A Phase 1, Open-label, 3-period, Randomized, Partially Fixed Sequence, 2-way Crossover Study With A Microdose Of [11c]Pf-06427878 Administered With And Without Two Non-radioactive Doses Of Pf-06427878 To Characterize Tissue Distribution Using Positron Emission Tomography In Healthy Adult Male Subjects
Phase of Trial: Phase I
Latest Information Update: 02 Nov 2015
At a glance
- Drugs PF 6427878 (Primary) ; PF 6427878 (Primary)
- Indications Hyperlipidaemia
- Focus Pharmacokinetics
- Sponsors Pfizer
- 28 Oct 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 21 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 24 Jun 2015 Status changed from not yet recruiting to recruiting.